ChemicalBook > CAS DataBase List > DCZ0415

DCZ0415

Product Name
DCZ0415
CAS No.
2242470-43-3
Chemical Name
DCZ0415
Synonyms
DCZ0415;DCZ0415, 10 mM in DMSO;2-(4-(Pyridin-4-ylmethyl)phenyl)-4,4a,5,5a,6,6a-hexahydro-4,6-ethenocyclopropa[f]isoindole-1,3(2H,3aH)-dione;4,6-Ethenocycloprop[f]isoindole-1,3(2H,3aH)-dione, 4,4a,5,5a,6,6a-hexahydro-2-[4-(4-pyridinylmethyl)phenyl]-;DCZ0415,DCZ 0415,Apoptosis,inhibit,nonhomologous,Nuclear factor-κB,TRIP13,Inhibitor,joining,DCZ-0415,end,drug-resistant,myeloma,repair,anti-myeloma,Nuclear factor-kappaB,NF-κB
CBNumber
CB48029461
Molecular Formula
C23H20N2O2
Formula Weight
356.42
MOL File
2242470-43-3.mol
More
Less

DCZ0415 Property

Boiling point:
624.2±55.0 °C(Predicted)
Density 
1.319±0.06 g/cm3(Predicted)
solubility 
DMSO:62.5(Max Conc. mg/mL);175.35(Max Conc. mM)
form 
Solid
pka
5.80±0.10(Predicted)
color 
Off-white to yellow
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Axon Medchem
Product number
Axon3216
Product name
DCZ0415
Purity
99%
Packaging
5mg
Price
$93.5
Updated
2021/12/16
ChemScene
Product number
CS-0109396
Product name
DCZ0415
Purity
99.96%
Packaging
5mg
Price
$145
Updated
2021/12/16
Axon Medchem
Product number
Axon3216
Product name
DCZ0415
Purity
99%
Packaging
2x5mg
Price
$154
Updated
2021/12/16
ChemScene
Product number
CS-0109396
Product name
DCZ0415
Purity
99.96%
Packaging
10mg
Price
$250
Updated
2021/12/16
ChemScene
Product number
CS-0109396
Product name
DCZ0415
Purity
99.96%
Packaging
25mg
Price
$530
Updated
2021/12/16
More
Less

DCZ0415 Chemical Properties,Usage,Production

Description

DCZ0415 is a novel inhibitor of TRIP13, suppressing multiple myeloma progression.

Uses

DCZ0415, a potent TRIP13 inhibitor, impairs nonhomologous end joining repair and inhibits NF-κB activity. DCZ0415 induces anti-myeloma activity in vitro, in vivo, and in primary cells derived from drug-resistant myeloma patients[1].

in vivo

DCZ0415 (ip; 50 mg/kg/day for 14 days) significantly reduces the growth of MM cells-induced tumors in immune-deficient mice[1].

Animal Model:Nude mice (6-weeks-old) with H929 775 cells[1]
Dosage:50 mg/kg
Administration:Intraperitoneal injection; every day for 14 days
Result:Significantly reduced the growth of MM cells-induced tumors.

target

DCZ0415, a potent TRIP13 inhibitor, impairs nonhomologous end joining repair and inhibits NF-κB activity.

IC 50

NF-κB

References

[1] Wang Y, et al. A Small Molecule Inhibitor Targeting TRIP13 suppresses multiple myeloma progression. Cancer Res. 2019 Nov 15. pii: canres.3987.2018. DOI:10.1158/0008-5472.CAN-18-3987

DCZ0415 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

DCZ0415 Suppliers

Shanghai Beckham Medical Technology Co., Ltd
Tel
13816613772
Fax
QQ: 12922499
Email
huahero21@sina.com
Country
China
ProdList
2495
Advantage
55
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9803
Advantage
58
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Fax
QQ:3008007432
Email
3008007409@qq.com
Country
China
ProdList
71826
Advantage
60
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8000
Advantage
62
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32470
Advantage
58
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6391
Advantage
58
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
Tel
18818260767
Fax
QQ 3610331285
Email
sales@chemegen.com
Country
China
ProdList
11218
Advantage
58
ShangHai ChuanQian Chemcial Technique Centre
Tel
15869524721
Email
3525679403@qq.com
Country
China
ProdList
4899
Advantage
58
cjbscvictory
Tel
13348960310
Email
3003867561@qq.com
Country
China
ProdList
10503
Advantage
58
Bide Pharmatech Ltd.
Tel
400-1647117 13681763483
Email
product02@bidepharm.com
Country
China
ProdList
59936
Advantage
58

2242470-43-3, DCZ0415Related Search:


  • DCZ0415
  • DCZ0415,DCZ 0415,Apoptosis,inhibit,nonhomologous,Nuclear factor-κB,TRIP13,Inhibitor,joining,DCZ-0415,end,drug-resistant,myeloma,repair,anti-myeloma,Nuclear factor-kappaB,NF-κB
  • 4,6-Ethenocycloprop[f]isoindole-1,3(2H,3aH)-dione, 4,4a,5,5a,6,6a-hexahydro-2-[4-(4-pyridinylmethyl)phenyl]-
  • 2-(4-(Pyridin-4-ylmethyl)phenyl)-4,4a,5,5a,6,6a-hexahydro-4,6-ethenocyclopropa[f]isoindole-1,3(2H,3aH)-dione
  • DCZ0415, 10 mM in DMSO
  • 2242470-43-3